Latest Breaking News On - Albert candia - Page 1 : comparemela.com

IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update - Data from T cell Engager Portfolio for Hematologic Malignancies, Including First. | November 3, 2022

United statesNew orleansAlbert candiaBispecific igDavid pittsFred schwarzerPreclinical sciencesSociety for immunotherapy of cancerBucknell universityAmerican society of hematologyCompany igBiosciences incExchange commissionDevelopment rd expensesVanderbilt university school of medicineBioanalytical development at nektar therapeutics